Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies
Clinical trial NCT02487459 · WITHDRAWN
Trial details
- NCT number
- NCT02487459
- Sponsor
- Bellicum Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2017-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.